Regal Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,170
Closed -$258K 500
2024
Q3
$258K Buy
2,170
+209
+11% +$27.9K 0.02% 475
2024
Q2
$280K Sell
1,961
-23
-1% -$3.05K 0.02% 478
2024
Q1
$255K Buy
+1,984
New +$236K 0.02% 494
2019
Q2
Sell
-7,806
Closed -$204K 357
2019
Q1
$204K Buy
+7,806
New +$192K 0.04% 293
2016
Q1
Sell
-7,272
Closed -$211K 277
2015
Q4
$211K Buy
7,272
+496
+7% +$13.7K 0.05% 239
2015
Q3
$183K Sell
6,776
-2,004
-23% -$56.7K 0.05% 247
2015
Q2
$240K Sell
8,780
-680
-7% -$19.1K 0.06% 221
2015
Q1
$253K Sell
9,460
-498
-5% -$11.5K 0.06% 223
2014
Q4
$211K Buy
9,958
+1,706
+21% +$38.1K 0.06% 219
2014
Q3
$196K Buy
8,252
+5,694
+223% +$131K 0.06% 221
2014
Q2
$59K Sell
2,558
-62
-2% -$1.37K 0.02% 357
2014
Q1
$60K Sell
2,620
-6,780
-72% -$144K 0.03% 323
2013
Q4
$35K Buy
9,400
+7,730
+463% +$135K 0.02% 348
2013
Q3
$28K Buy
+1,670
New +$28.1K 0.02% 409

Other funds holding NVO

Regal Investment Advisors's NVO Position: Q4 2024 in Review

Regal Investment Advisors sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,170 shares — an estimated $258K sold.

Regal Investment Advisors first reported a position in NVO in Q3 2013 and held it in 14 quarters. The position peaked at $280K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Regal Investment Advisors reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Regal Investment Advisors sold 2,170 Novo Nordisk shares in Q4 2024, an estimated $258K.
  • Regal Investment Advisors first reported a position in Novo Nordisk in Q3 2013 and held it in 14 quarters.
  • Regal Investment Advisors's Novo Nordisk position peaked at $280K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Regal Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.